nodes	percent_of_prediction	percent_of_DWPC	metapath
Tocainide—CYP1A2—type 2 diabetes mellitus	0.25	0.634	CbGaD
Tocainide—ALB—type 2 diabetes mellitus	0.144	0.366	CbGaD
Tocainide—ALB—Gliclazide—type 2 diabetes mellitus	0.0655	0.158	CbGbCtD
Tocainide—ALB—Repaglinide—type 2 diabetes mellitus	0.0616	0.149	CbGbCtD
Tocainide—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0514	0.124	CbGbCtD
Tocainide—ALB—Valsartan—type 2 diabetes mellitus	0.0454	0.11	CbGbCtD
Tocainide—ALB—Nateglinide—type 2 diabetes mellitus	0.0422	0.102	CbGbCtD
Tocainide—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0308	0.0742	CbGbCtD
Tocainide—ALB—Glyburide—type 2 diabetes mellitus	0.0285	0.0688	CbGbCtD
Tocainide—ALB—Losartan—type 2 diabetes mellitus	0.0261	0.063	CbGbCtD
Tocainide—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0242	0.0585	CbGbCtD
Tocainide—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0229	0.0553	CbGbCtD
Tocainide—CYP1A2—Losartan—type 2 diabetes mellitus	0.0156	0.0377	CbGbCtD
Tocainide—SCN11A—peripheral nervous system—type 2 diabetes mellitus	0.00759	0.163	CbGeAlD
Tocainide—SCN11A—nerve—type 2 diabetes mellitus	0.00591	0.127	CbGeAlD
Tocainide—SCN8A—peripheral nervous system—type 2 diabetes mellitus	0.00575	0.123	CbGeAlD
Tocainide—SCN8A—nerve—type 2 diabetes mellitus	0.00448	0.096	CbGeAlD
Tocainide—SCN10A—peripheral nervous system—type 2 diabetes mellitus	0.00385	0.0824	CbGeAlD
Tocainide—SCN10A—nerve—type 2 diabetes mellitus	0.003	0.0643	CbGeAlD
Tocainide—SCN7A—cardiovascular system—type 2 diabetes mellitus	0.00176	0.0378	CbGeAlD
Tocainide—SCN7A—adipose tissue—type 2 diabetes mellitus	0.00155	0.0333	CbGeAlD
Tocainide—SCN9A—nephron tubule—type 2 diabetes mellitus	0.00154	0.0329	CbGeAlD
Tocainide—SCN9A—adipose tissue—type 2 diabetes mellitus	0.00122	0.0261	CbGeAlD
Tocainide—SCN4A—kidney—type 2 diabetes mellitus	0.0012	0.0258	CbGeAlD
Tocainide—SCN10A—nephron tubule—type 2 diabetes mellitus	0.00117	0.0251	CbGeAlD
Tocainide—SCN7A—liver—type 2 diabetes mellitus	0.00109	0.0233	CbGeAlD
Tocainide—SCN4A—adipose tissue—type 2 diabetes mellitus	0.00109	0.0233	CbGeAlD
Tocainide—SCN2A—cortex of kidney—type 2 diabetes mellitus	0.00104	0.0222	CbGeAlD
Tocainide—SCN5A—cardiovascular system—type 2 diabetes mellitus	0.000955	0.0205	CbGeAlD
Tocainide—SCN3A—kidney—type 2 diabetes mellitus	0.000937	0.0201	CbGeAlD
Tocainide—SCN3A—cortex of kidney—type 2 diabetes mellitus	0.000912	0.0196	CbGeAlD
Tocainide—SCN3A—adipose tissue—type 2 diabetes mellitus	0.000844	0.0181	CbGeAlD
Tocainide—Mexiletine—CYP2E1—type 2 diabetes mellitus	0.000796	0.153	CrCbGaD
Tocainide—Mexiletine—CYP1A2—type 2 diabetes mellitus	0.000757	0.145	CrCbGaD
Tocainide—Levobupivacaine—CYP1A2—type 2 diabetes mellitus	0.000554	0.106	CrCbGaD
Tocainide—Mexiletine—CYP3A4—type 2 diabetes mellitus	0.000501	0.0963	CrCbGaD
Tocainide—ALB—liver—type 2 diabetes mellitus	0.000473	0.0101	CbGeAlD
Tocainide—Lidocaine—EGFR—type 2 diabetes mellitus	0.00047	0.0903	CrCbGaD
Tocainide—Bupivacaine—CYP1A2—type 2 diabetes mellitus	0.000443	0.0851	CrCbGaD
Tocainide—Levobupivacaine—CYP3A4—type 2 diabetes mellitus	0.000367	0.0705	CrCbGaD
Tocainide—Ropivacaine—CYP1A2—type 2 diabetes mellitus	0.000357	0.0686	CrCbGaD
Tocainide—CYP1A2—liver—type 2 diabetes mellitus	0.000311	0.00666	CbGeAlD
Tocainide—Bupivacaine—CYP3A4—type 2 diabetes mellitus	0.000293	0.0563	CrCbGaD
Tocainide—Lidocaine—CYP1A2—type 2 diabetes mellitus	0.000259	0.0498	CrCbGaD
Tocainide—Ropivacaine—CYP3A4—type 2 diabetes mellitus	0.000236	0.0454	CrCbGaD
Tocainide—Lidocaine—CYP3A4—type 2 diabetes mellitus	0.000172	0.033	CrCbGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	1.62e-05	0.000116	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	1.62e-05	0.000116	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.62e-05	0.000116	CbGpPWpGaD
Tocainide—ALB—Hemostasis—NOS1—type 2 diabetes mellitus	1.62e-05	0.000115	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.61e-05	0.000115	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—IL6—type 2 diabetes mellitus	1.6e-05	0.000114	CbGpPWpGaD
Tocainide—ALB—Metabolism—G6PC—type 2 diabetes mellitus	1.6e-05	0.000114	CbGpPWpGaD
Tocainide—ALB—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.6e-05	0.000114	CbGpPWpGaD
Tocainide—ALB—Metabolism—ENPP1—type 2 diabetes mellitus	1.6e-05	0.000114	CbGpPWpGaD
Tocainide—ALB—Metabolism—ND1—type 2 diabetes mellitus	1.6e-05	0.000114	CbGpPWpGaD
Tocainide—ALB—Metabolism—HBA2—type 2 diabetes mellitus	1.6e-05	0.000114	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—BHMT—type 2 diabetes mellitus	1.59e-05	0.000114	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—SERPINE1—type 2 diabetes mellitus	1.58e-05	0.000112	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PTPN1—type 2 diabetes mellitus	1.57e-05	0.000112	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	1.57e-05	0.000112	CbGpPWpGaD
Tocainide—ALB—Metabolism—GCGR—type 2 diabetes mellitus	1.55e-05	0.000111	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—SRC—type 2 diabetes mellitus	1.55e-05	0.000111	CbGpPWpGaD
Tocainide—ALB—Hemostasis—RASGRP1—type 2 diabetes mellitus	1.55e-05	0.00011	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—AKT1—type 2 diabetes mellitus	1.55e-05	0.00011	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—IL6—type 2 diabetes mellitus	1.54e-05	0.00011	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—IL6—type 2 diabetes mellitus	1.54e-05	0.00011	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—VEGFA—type 2 diabetes mellitus	1.51e-05	0.000108	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—PIK3R1—type 2 diabetes mellitus	1.51e-05	0.000107	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	1.5e-05	0.000107	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.49e-05	0.000106	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—IL6—type 2 diabetes mellitus	1.49e-05	0.000106	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—IL6—type 2 diabetes mellitus	1.49e-05	0.000106	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—AKT1—type 2 diabetes mellitus	1.48e-05	0.000106	CbGpPWpGaD
Tocainide—ALB—Metabolism—OXCT1—type 2 diabetes mellitus	1.47e-05	0.000105	CbGpPWpGaD
Tocainide—ALB—Metabolism—CYTB—type 2 diabetes mellitus	1.47e-05	0.000105	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—IL6—type 2 diabetes mellitus	1.46e-05	0.000104	CbGpPWpGaD
Tocainide—ALB—Metabolism—SRD5A1—type 2 diabetes mellitus	1.43e-05	0.000102	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—AKT1—type 2 diabetes mellitus	1.42e-05	0.000101	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—AKT1—type 2 diabetes mellitus	1.42e-05	0.000101	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.42e-05	0.000101	CbGpPWpGaD
Tocainide—ALB—Hemostasis—SOD1—type 2 diabetes mellitus	1.4e-05	0.0001	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—AANAT—type 2 diabetes mellitus	1.39e-05	9.92e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PTGDS—type 2 diabetes mellitus	1.39e-05	9.92e-05	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—TGFB1—type 2 diabetes mellitus	1.39e-05	9.89e-05	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—AKT1—type 2 diabetes mellitus	1.37e-05	9.78e-05	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—AKT1—type 2 diabetes mellitus	1.37e-05	9.78e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—HSD17B3—type 2 diabetes mellitus	1.36e-05	9.72e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—ACACA—type 2 diabetes mellitus	1.36e-05	9.72e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—STAR—type 2 diabetes mellitus	1.36e-05	9.72e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.36e-05	9.72e-05	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—EGFR—type 2 diabetes mellitus	1.36e-05	9.7e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—GNB3—type 2 diabetes mellitus	1.36e-05	9.68e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—IGF2—type 2 diabetes mellitus	1.33e-05	9.51e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.32e-05	9.44e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CDO1—type 2 diabetes mellitus	1.32e-05	9.41e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GPD2—type 2 diabetes mellitus	1.32e-05	9.41e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—ABCC8—type 2 diabetes mellitus	1.31e-05	9.32e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CBS—type 2 diabetes mellitus	1.31e-05	9.32e-05	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—TNF—type 2 diabetes mellitus	1.29e-05	9.23e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—APOB—type 2 diabetes mellitus	1.29e-05	9.23e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.29e-05	9.19e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.28e-05	9.14e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—AK1—type 2 diabetes mellitus	1.26e-05	8.97e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—SLC5A2—type 2 diabetes mellitus	1.26e-05	8.97e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—COX2—type 2 diabetes mellitus	1.26e-05	8.97e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.24e-05	8.87e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—NCOA6—type 2 diabetes mellitus	1.24e-05	8.82e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.24e-05	8.81e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—UCP3—type 2 diabetes mellitus	1.22e-05	8.67e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—HSD11B1—type 2 diabetes mellitus	1.22e-05	8.67e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—UCP2—type 2 diabetes mellitus	1.22e-05	8.67e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.18e-05	8.4e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.17e-05	8.38e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—CD36—type 2 diabetes mellitus	1.17e-05	8.37e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.17e-05	8.34e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SLC5A4—type 2 diabetes mellitus	1.16e-05	8.28e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—MAT1A—type 2 diabetes mellitus	1.16e-05	8.28e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	1.16e-05	8.27e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.16e-05	8.27e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.16e-05	8.25e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—PCK1—type 2 diabetes mellitus	1.14e-05	8.15e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.13e-05	8.09e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.12e-05	8.02e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.12e-05	8.02e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—HBA2—type 2 diabetes mellitus	1.12e-05	8e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.12e-05	8e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ND1—type 2 diabetes mellitus	1.12e-05	8e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ENPP1—type 2 diabetes mellitus	1.12e-05	8e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—G6PC—type 2 diabetes mellitus	1.12e-05	8e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.12e-05	7.99e-05	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	1.11e-05	7.94e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.1e-05	7.83e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GCGR—type 2 diabetes mellitus	1.09e-05	7.75e-05	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	1.08e-05	7.73e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	1.07e-05	7.63e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—HK1—type 2 diabetes mellitus	1.07e-05	7.63e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.07e-05	7.62e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.05e-05	7.47e-05	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—IL6—type 2 diabetes mellitus	1.04e-05	7.45e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	1.04e-05	7.41e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—GCKR—type 2 diabetes mellitus	1.03e-05	7.37e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	1.03e-05	7.37e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	1.03e-05	7.37e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—LPA—type 2 diabetes mellitus	1.03e-05	7.37e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CYTB—type 2 diabetes mellitus	1.03e-05	7.32e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—OXCT1—type 2 diabetes mellitus	1.03e-05	7.32e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	1.02e-05	7.3e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SRD5A1—type 2 diabetes mellitus	1e-05	7.13e-05	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	9.95e-06	7.1e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	9.94e-06	7.09e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	9.91e-06	7.07e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	9.77e-06	6.97e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	9.65e-06	6.88e-05	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—AKT1—type 2 diabetes mellitus	9.64e-06	6.87e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	9.62e-06	6.86e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	9.54e-06	6.8e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	9.54e-06	6.8e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	9.54e-06	6.8e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	9.45e-06	6.74e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	9.43e-06	6.72e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	9.32e-06	6.65e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	9.21e-06	6.57e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	9.14e-06	6.52e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	9.14e-06	6.52e-05	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.86e-06	6.32e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	8.8e-06	6.28e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	8.8e-06	6.28e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	8.65e-06	6.17e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	8.64e-06	6.16e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	8.6e-06	6.13e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	8.56e-06	6.1e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	8.55e-06	6.1e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	8.5e-06	6.06e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	8.5e-06	6.06e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	8.5e-06	6.06e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—MTR—type 2 diabetes mellitus	8.42e-06	6.01e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	8.42e-06	6.01e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	8.26e-06	5.89e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	8.24e-06	5.88e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	8.21e-06	5.86e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—HBA1—type 2 diabetes mellitus	8.21e-06	5.85e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—LIPC—type 2 diabetes mellitus	8.21e-06	5.85e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—GCK—type 2 diabetes mellitus	8.21e-06	5.85e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	8.16e-06	5.82e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	8.13e-06	5.8e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	8.01e-06	5.71e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	7.99e-06	5.7e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CETP—type 2 diabetes mellitus	7.92e-06	5.65e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	7.87e-06	5.61e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	7.76e-06	5.53e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	7.76e-06	5.53e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	7.68e-06	5.47e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	7.48e-06	5.34e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	7.47e-06	5.33e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	7.36e-06	5.25e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	7.36e-06	5.25e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	7.36e-06	5.25e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	7.23e-06	5.15e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	7.23e-06	5.15e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	7.23e-06	5.15e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	7.23e-06	5.15e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CTGF—type 2 diabetes mellitus	7.23e-06	5.15e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	7.16e-06	5.11e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.06e-06	5.04e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	7.01e-06	5e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.95e-06	4.96e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	6.93e-06	4.94e-05	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	6.92e-06	4.93e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	6.73e-06	4.8e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.73e-06	4.8e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	6.66e-06	4.75e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	6.66e-06	4.75e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.59e-06	4.7e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.52e-06	4.65e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	6.49e-06	4.63e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.46e-06	4.61e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	6.44e-06	4.59e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—GCG—type 2 diabetes mellitus	6.38e-06	4.55e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	6.38e-06	4.55e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	6.01e-06	4.29e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	5.89e-06	4.2e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	5.89e-06	4.2e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	5.78e-06	4.12e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.74e-06	4.1e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	5.74e-06	4.09e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	5.74e-06	4.09e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	5.74e-06	4.09e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—SRC—type 2 diabetes mellitus	5.74e-06	4.09e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	5.71e-06	4.07e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	5.6e-06	4e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	5.59e-06	3.99e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	5.54e-06	3.95e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—GNB3—type 2 diabetes mellitus	5.5e-06	3.92e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.5e-06	3.92e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	5.48e-06	3.91e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CAT—type 2 diabetes mellitus	5.4e-06	3.85e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—APOB—type 2 diabetes mellitus	5.25e-06	3.74e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.16e-06	3.68e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	5.15e-06	3.67e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	5.15e-06	3.67e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	5.15e-06	3.67e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	5.13e-06	3.66e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	5.1e-06	3.64e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	5.05e-06	3.61e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	5.01e-06	3.57e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—LPL—type 2 diabetes mellitus	5.01e-06	3.57e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.94e-06	3.52e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	4.9e-06	3.5e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.9e-06	3.5e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—GPX1—type 2 diabetes mellitus	4.89e-06	3.49e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CD36—type 2 diabetes mellitus	4.76e-06	3.39e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.71e-06	3.36e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	4.7e-06	3.35e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	4.66e-06	3.32e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.54e-06	3.24e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.52e-06	3.22e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	4.51e-06	3.22e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	4.46e-06	3.18e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	4.46e-06	3.18e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—PPARA—type 2 diabetes mellitus	4.42e-06	3.16e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—AGT—type 2 diabetes mellitus	4.29e-06	3.06e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—CALM1—type 2 diabetes mellitus	4.21e-06	3.01e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—APOE—type 2 diabetes mellitus	4.2e-06	2.99e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—APOA1—type 2 diabetes mellitus	4.15e-06	2.96e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.85e-06	2.74e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.85e-06	2.74e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.83e-06	2.73e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.78e-06	2.7e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.67e-06	2.62e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—PPARG—type 2 diabetes mellitus	3.66e-06	2.61e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—INS—type 2 diabetes mellitus	3.59e-06	2.56e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.57e-06	2.55e-05	CbGpPWpGaD
Tocainide—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	3.57e-06	2.54e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	3.5e-06	2.5e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.43e-06	2.45e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.42e-06	2.44e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	3.33e-06	2.37e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.29e-06	2.34e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.15e-06	2.25e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	3.15e-06	2.24e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—NOS3—type 2 diabetes mellitus	3.15e-06	2.24e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.09e-06	2.21e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	3e-06	2.14e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.95e-06	2.1e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.94e-06	2.09e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.9e-06	2.07e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	2.88e-06	2.05e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.56e-06	1.82e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.51e-06	1.79e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.3e-06	1.64e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.2e-06	1.57e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.2e-06	1.57e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.01e-06	1.44e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.45e-06	1.03e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.01e-06	7.21e-06	CbGpPWpGaD
